|
|
 |
Your Online Resource for Diabetes Treatment
Home > Literature
Alerts > Archived
by Journal > Diabetic Medicine
Diabetic Medicine | 
|
| |
Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus
Vilsbøll T, Brock B, Perrild H, et al Diabet Med. 2008;25(2):152-156 |
| |
Rosiglitazone RECORD study: glucose control outcomes at 18 months
Home PD, Jones NP, Pocock SJ, et al Diabet Med. 2007;24:626–634 |
| |
Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes
Delahanty LM, Grant RW, Wittenberg E, et al Diabet Med. 2007;24:48-54 |
| |
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT Study.
Gerstein HC, Yale JF, Harris SB, et al Diabet Med. 2006;23:736-742 |
| |
Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study
Bowden DW, Lohman K, Hsu FC, et al Diabet Med. 2006;23:763-767 |
| |
Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?
Hughes RC, Rowan JA Diabet Med. 2006;23:318-322 |
| |
Metformin use and diabetic pregnancy-has its time come?
Hawthorne G Diabet Med. 2006;23:223-227 |
| |
Pathophysiology of ketoacidosis in Type 2 diabetes mellitus
Linfoot P, Bergstrom C, Ipp E Diabet Med. 2005;22:1414-1419 |
| |
Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus
Roden M, Laakso M, Johns D, et al Diabet Med. 2005;22:1101-1106 |
| |
Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population
Nagaya T, Yoshida H, Takahashi H, Kawai M Diabet Med. 2005;22:1107-1111 |
| |
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial
Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P Diabet Med. 2005;22:399-405 |
|